Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294019 · ClinicalTrials.gov registry record · Phase 3
Actual Use Trial of Ibuprofen 400 mg
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 738
- Enrollment target
NCT02294019 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 738 participants.
The verdict
NCT02294019, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 738 participants
- Enrollment target
Study Summary
This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.
Interventions
- DRUG Ibuprofen 400 mg caplet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 738 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02294019
The ClinicalTrials.gov registry entry for NCT02294019 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 738 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ibuprofen 400 mg caplet is the first listed.
NCT02294019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02294019 about?
NCT02294019 is a clinical study titled "Actual Use Trial of Ibuprofen 400 mg". This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.
What is the current status of trial NCT02294019?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 738 participants. The study started on 2014-11. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02294019?
The interventions under investigation include: Ibuprofen 400 mg caplet (DRUG).
Who is sponsoring clinical trial NCT02294019?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.